Clinical Trial Update: Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. [Phase 1]

View source ↗

Summary

Phase 1 safety and immunogenicity study of a serogroup B meningococcal vaccine to prevent meningitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Group B Meningococcal Vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Meningitis, Meningococcal, Serogroup B | Phase 1 | Status: COMPLETED | Results posted: 2018-10-29